Retraction: Small interfering RNA-induced silencing of galectin-3 inhibits the malignant phenotypes of osteosarcoma in vitro (Molecular Medicine Reports (2015) 12 (6316-6322) DOI: 10.3892/mmr.2015.4165);Small interfering RNA-induced silencing of galectin-3 inhibits the malignant phenotypes of osteosarcoma in vitro

Molecular Medicine Reports

Volumn 12, Issue 4, 2015, Pages 6316-6322

  Lei, Pengfei ^a   He, Hongbo ^a   Hu, Yihe ^a   Liao, Zhan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Galectin 3; Invasion; Migration; Osteosarcoma; Proliferation

Indexed keywords

GALECTIN 3; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE KINASE; SMALL INTERFERING RNA; GALECTIN-3, HUMAN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOBLAST; OSTEOSARCOMA; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; BONE NEOPLASMS; CELL MOTION; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GALECTIN 3; GENE SILENCING; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OSTEOSARCOMA; PHENOTYPE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84940500789     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2021.12309     Document Type: Erratum

References (26)

1. Thompson LD: Osteosarcoma. Ear Nose Throat J 92: 288-290, 2013.
2. Yang J and Zhang W: New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol 25: 398-406, 2013.
3. Fortuna-Costa A, Gomes AM, Kozlowski EO, Stelling MP and Pavão MS: Extracellular galectin-3 in tumor progression and metastasis. Front Oncol 4: 138, 2014.
4. Viguier M, Advedissian T, Delacour D, Poirier F and Deshayes F: Galectins in epithelial functions. Tissue Barriers 2: e29103, 2014.
5. Laderach DJ, Gentilini L, Jaworski FM and Compagno D: Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers. Prostate Cancer 2013: 519436, 2013.
6. Eisa NH, Ebrahim MA, Ragab M, Eissa LA and El-Gayar AM: Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma. J Oncol Pharm Pract, 2014 (Epub ahead of print).
7. von Klot CA, Kramer MW, Peters I, Hennenlotter J, Abbas M, Scherer R, Herrmann TR, Stenzl A, Kuczyk MA, Serth J and Merseburger AS: Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma. BMC Clin Pathol 14: 15, 2014.
8. Zhou X, Jing J, Peng J, Mao W, Zheng Y, Wang D, Wang X, Liu Z and Zhang X: Expression and clinical signifcance of galectin-3 in osteosarcoma. Gene 546: 403-407, 2014.
9. Hou F, Wang L, Wang H, Gu J, Li M, Zhang J, Ling X, Gao X, and Luo C: Elevated gene expression of S100A12 is correlated with the predominant clinical infammatory factors in patients with bacterial pneumonia. Mol Med Rep 11: 4345-4352, 2015.
10. Gao J, Ding F, Liu Q and Yao Y: Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem 376: 21-32, 2013.
11. Miao JH, Wang SQ, Zhang MH, Yu FB, Zhang L, Yu ZX and Kuang Y: Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway. Oncol Rep 32: 1497-1504, 2014.
12. Tsubaki M, Satou T, Itoh T, Imano M, Ogaki M, Yanae M and Nishida S: Reduction of metastasis, cell invasion and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway. Toxicol Appl Pharmacol 259: 402-410, 2012.
13. Diao CY, Guo HB, Ouyang YR, Zhang HC, Liu LH, Bu J, Wang ZH and Xiao T: Screening for metastatic osteosarcoma biomarkers with a DNA microarray. Asian Pac J Cancer Prev 15: 1817-1822, 2014.
14. Gao P, Simpson JL, Zhang J and Gibson PG: Galectin-3: Its role in asthma and potential as an anti-infammatory target. Respir Res 14: 136, 2013.
15. Sundblad V, Croci DO and Rabinovich GA: Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues. Histol Histopathol 26: 247-265, 2011.
16. Funasaka T, Raz A and Nangia-Makker P: Galectin-3 in angio-genesis and metastasis. Glycobiology 24: 886-891, 2014.
17. Leal MF, Calcagno DQ, Chung J, de Freitas VM, Demachki S, Assumpção PP, Chammas R, Burbano RR and Smith MC: Deregulated expression of annexin-A2 and galectin-3 is associated with metastasis in gastric cancer patients. Clin Exp Med, 2014 (Epub ahead of print).
18. Truran PP, Johnson SJ, Bliss RD, Lennard TW and Aspinall SR: Parafbromin, galectin-3, PGP9.5, Ki67 and cyclin D1: Using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer. World J Surg 38: 2845-2854, 2014.
19. Mirandola L, Nguyen DD, Rahman RL, Grizzi F, Yuefei Y, Figueroa JA, Jenkins MR, Cobos E and Chiriva-Internati M: Anti-Galectin-3 therapy: A new chance for multiple myeloma and ovarian cancer? Int Rev Immunol 33: 417-427, 2014.
20. van den Brûle F, Califce S and Castronovo V: Expression of galectins in cancer: A critical review. Glycoconj J 19: 537-542, 2004.
21. Zheng D, Hu Z, He F, Gao C, Xu L, Zou H, Wu Z, Jiang X and Wang J: Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells. Oncol Rep 32: 411-418, 2014.
22. Huang CX, Zhao JN, Zou WH, Li JJ, Wang PC, Liu CH and Wang YB: Reduction of galectin-3 expression reduces pituitary tumor cell progression. Genet Mol Res 13: 6892-6898, 2014.
23. Wang Y, Balan V, Kho D, Hogan V, Nangia-Makker P and Raz A: Galectin-3 regulates p21 stability in human prostate cancer cells. Oncogene 32: 5058-5065, 2013.
24. Kosacka M, Piesiak P, Kowal A, Golecki M and Jankowska R: Galectin-3 and cyclin D1 expression in non-small cell lung cancer. J Exp Clin Cancer Res 30: 101, 2011.
25. Zhang D, Chen ZG, Liu SH, Dong ZQ, Dalin M, Bao SS, Hu YW and Wei FC: Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-catenin. Acta Pharmacol Sin 34: 176-184, 2013.
26. Song S, Ji B, Ramachandran V, Wang H, Hafey M, Logsdon C and Bresalier RS: Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. PLoS One 7: e42699, 2012.